SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950142-12-001622
Filing Date
2012-07-26
Accepted
2012-07-25 21:04:45
Documents
4
Group Members
AISLING CAPITAL III LPAISLING CAPITAL PARTNERS III LLCAISLING CAPITAL PARTNERS III LPANDREW SCHIFFDENNIS PURCELLSTEVE ELMS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D eh1200922_13d-durata.htm SC 13D 240577
2 EXHIBIT 1 eh1200922_ex1.htm EX-99.1 30823
3 EXHIBIT 2 eh1200922_ex2.htm EX-99.2 36271
4 EXHIBIT 3 eh1200922_ex3.htm EX-99.3 7415
  Complete submission text file 0000950142-12-001622.txt   316789
Mailing Address 888 Seventh Avenue, 30th Fl New York NY 10106
Business Address 888 Seventh Avenue, 30th Fl New York NY 10106 212-651-6380
AISLING CAPITAL III LP (Filed by) CIK: 0001444717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D

Mailing Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760
Business Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760 973-993-4867
Durata Therapeutics, Inc. (Subject) CIK: 0001544116 (see all company filings)

IRS No.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86923 | Film No.: 12985671
SIC: 2834 Pharmaceutical Preparations